Norman C. Selby - 16 Jun 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC.

Role
Director
Signature
/s/Seth A. Tasker as attorney-in-fact for Norman C. Selby
Issuer symbol
N/A
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
16 Jun 2022, 20:37:31 UTC
Previous filing
11 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option(right to buy) Award $0 +45,000 $0.000000 45,000 16 Jun 2022 Common Stock 45,000 $0.6790 Direct F1
transaction INFI Stock Option(right to buy) Award $0 +10,000 $0.000000 10,000 16 Jun 2022 Common Stock 10,000 $0.6790 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
F2 The option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as Lead Independent Director of the issuer's Board of Directors.

Remarks:

Exhibit 24 - Limited Power of Attorney